The studies presented above confirmed the crucial role of anti-apoptotic molecules such as Bim, Bmf, Bax, Bak, anti-apoptotic Bcl-2 family proteins and several IAPs in controlling melanoma sensitivity to inhibitors of the MAPK pathway. The gene discussed is BCL2L11; the disease is melanoma.